quinoxalines has been researched along with pituitrin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DP; Depalma, PD; Edwards, RM; Fredrickson, TA; Gellai, M; Hieble, JP | 1 |
| Rand, MJ; Xiao, XH | 1 |
| Hicks, PE; Waldron, CJ | 1 |
| Crowley, WR; Parker, SL | 1 |
| Heary, RF; Krieger, AJ; Maniker, AH; Sapru, HN | 1 |
| Cui, LN; Dyball, RE; Saeb-Parsy, K | 1 |
| Badre, SE; Morsette, DJ; Sidorowicz, HE; Sladek, CD | 1 |
| Badre, SE; Morsette, DJ; Sladek, CD; Swenson, KL | 1 |
| Armstrong, WE; Foehring, RC; Galarreta, M; Hestrin, S; Stern, JE | 1 |
| Ezure, Y; Hasegawa, H; Kawano, K; Matsukawa, H; Morizono, D; Naito, A; Naito, K; Oguma, T; Ohtake, Y; Tanaka, Y; Taniguchi, M; Tsuriya, Y | 1 |
| Briski, KP | 1 |
| Buijs, RM; Hermes, ML; Klop, A; Renaud, LP; Ruijter, JM | 1 |
| Gao, L; Jackson, EK; Zhu, C | 1 |
| Antunes-Rodrigues, J; Busnardo, C; Corrêa, FM; Tavares, RF | 1 |
| Carrillo, M; Melloni, RH; Ricci, LA | 1 |
| Antunes-Rodrigues, J; Busnardo, C; Corrêa, FM; Crestani, CC; Resstel, LB; Tavares, RF | 1 |
| Althammer, F; Busnelli, M; Chao, MV; Charlet, A; Chavant, V; Chini, B; Ciobanu, AC; da Silva Gouveia, M; Eliava, M; Froemke, RC; Giese, G; Goumon, Y; Grinevich, V; Gruber, T; Knobloch-Bollmann, HS; Kuner, R; Melchior, M; Mitre, M; Petit-Demoulière, N; Poisbeau, P; Roth, LC; Seeburg, PH; Sprengel, R; Stoop, R; Tan, LL; Tang, Y; Triana Del Rio, R; Wahis, J | 1 |
17 other study(ies) available for quinoxalines and pituitrin
| Article | Year |
|---|---|
The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent.
Topics: Adrenergic alpha-Agonists; Animals; Consciousness; Cyclic AMP; Diuretics; Dogs; Dose-Response Relationship, Drug; Female; Imidazoles; Kidney Concentrating Ability; Kidney Tubules, Collecting; Macaca fascicularis; Male; Quinoxalines; Rats; Rats, Inbred Strains; Species Specificity; Urodynamics; Vasopressins; Water | 1991 |
Effects of the alpha 2-adrenoceptor agonist UK14304 on pressor responses in pithed rats.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Decerebrate State; Dose-Response Relationship, Drug; Drug Synergism; Norepinephrine; Phenylephrine; Prazosin; Pressoreceptors; Quinoxalines; Rats; Vasopressins; Yohimbine | 1990 |
Relative contribution of different vascular beds to the pressor effects of alpha-adrenoreceptor agonists and vasopressin in pithed rats: radioactive microsphere determination.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Brimonidine Tartrate; Chromium Radioisotopes; Decerebrate State; Male; Methoxamine; Microspheres; Quinoxalines; Rats; Rats, Inbred Strains; Vasoconstriction; Vasopressins | 1985 |
Stimulation of oxytocin release in the lactating rat by central excitatory amino acid mechanisms: evidence for specific involvement of R,S-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-sensitive glutamate receptors.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids; Animals; Brain; Calcium Channel Blockers; Female; Lactation; Oxytocin; Prolactin; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Glutamate; Sodium Channel Blockers; Vasopressins | 1993 |
Cardiovascular responses to global cerebral ischemia: role of excitatory amino acids in the ventrolateral medullary pressor area.
Topics: Acetylcholine; Amino Acids; Animals; Antidiuretic Hormone Receptor Antagonists; Atropine; Blood Pressure; Brain Ischemia; Dose-Response Relationship, Drug; Glutamates; Heart Rate; Kainic Acid; Kynurenic Acid; Male; Medulla Oblongata; Muscimol; N-Methylaspartate; Quinoxalines; Quisqualic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Vasopressin; Vasopressins | 1993 |
Neurones in the supraoptic nucleus of the rat are regulated by a projection from the suprachiasmatic nucleus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Bicuculline; Evoked Potentials; Excitatory Amino Acid Antagonists; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Neural Pathways; Neurons; Optic Nerve; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Wistar; Receptors, GABA-A; Suprachiasmatic Nucleus; Supraoptic Nucleus; Vasopressins | 1997 |
Role of non-NMDA receptors in osmotic and glutamate stimulation of vasopressin release: effect of rapid receptor desensitization.
Topics: Animals; Benzothiadiazines; Concanavalin A; Down-Regulation; Excitatory Amino Acid Antagonists; Glutamic Acid; Hypothalamo-Hypophyseal System; In Vitro Techniques; Magnesium; Male; Osmolar Concentration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Sodium Chloride; Vasopressins | 1998 |
Regulation of vasopressin release by ionotropic glutamate receptor agonists.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Hypothalamo-Hypophyseal System; Kainic Acid; N-Methylaspartate; Organ Culture Techniques; Quinoxalines; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Vasopressins | 1998 |
Differences in the properties of ionotropic glutamate synaptic currents in oxytocin and vasopressin neuroendocrine neurons.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Evoked Potentials; Excitatory Amino Acid Antagonists; Female; Hypothalamus; In Vitro Techniques; Neurons; Oxytocin; Patch-Clamp Techniques; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Supraoptic Nucleus; Synapses; Vasopressins | 1999 |
Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzodiazepines; Diuresis; Diuretics; In Vitro Techniques; Pyrroles; Quinoxalines; Rats; Structure-Activity Relationship; Vasopressins | 1999 |
Pharmacological manipulation of central nitric oxide/guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation.
Topics: Animals; Deoxyglucose; Enzyme Inhibitors; Glucose; Guanylate Cyclase; Hypothalamus; Immunoenzyme Techniques; Male; Molsidomine; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxadiazoles; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Vasopressins | 1999 |
Vasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro.
Topics: Action Potentials; Animals; Bicuculline; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Interneurons; Male; Neural Inhibition; Oxytocin; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Long-Evans; Receptors, GABA-A; Synaptic Transmission; Tetrodotoxin; Vasoconstrictor Agents; Vasopressins | 2000 |
alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Angiotensin II; Animals; Blotting, Western; Brimonidine Tartrate; Capillaries; Drug Synergism; GTP-Binding Protein alpha Subunits, Gi-Go; In Vitro Techniques; Male; Pertussis Toxin; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Vasopressin; Renal Circulation; Signal Transduction; Vasoconstrictor Agents; Vasopressins | 2003 |
Cardiovascular effects of L-glutamate microinjection in the supraoptic nucleus of unanaesthetized rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Excitatory Amino Acid Antagonists; Ganglionic Blockers; Glutamic Acid; Heart Rate; Isoquinolines; Male; Microinjections; Pentolinium Tartrate; Quinoxalines; Rats; Rats, Wistar; Supraoptic Nucleus; Vasopressins | 2007 |
Glutamate-vasopressin interactions and the neurobiology of anabolic steroid-induced offensive aggression.
Topics: Age Factors; Aggression; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anabolic Agents; Animals; Animals, Newborn; Arginine Vasopressin; Behavior, Animal; Cricetinae; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Hormone Antagonists; Hypothalamic Area, Lateral; Male; Mesocricetus; Microinjections; Quinoxalines; Septal Nuclei; Statistics, Nonparametric; Steroids; Vasopressins; Vesicular Glutamate Transport Protein 2 | 2011 |
Ionotropic glutamate receptors in hypothalamic paraventricular and supraoptic nuclei mediate vasopressin and oxytocin release in unanesthetized rats.
Topics: Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Microinjections; N-Methylaspartate; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Supraoptic Nucleus; Vasopressins | 2012 |
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing.
Topics: Action Potentials; Animals; Cholecystokinin; Disease Models, Animal; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Inflammation; Neural Pathways; Neuralgia; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Receptors, Oxytocin; Spinal Cord; Supraoptic Nucleus; Transduction, Genetic; Vasopressins; Vesicular Glutamate Transport Protein 2 | 2016 |